Skip to main
NGEN

NGEN Market Capitalization Overview

Market Cap: $335.89M as of Feb 3, 2026

$335.89M
$132.13M (28.23%)past month
As of Feb 3, 2026, NGEN has a market capitalization of $335.89M. Over the past 30 days, its market cap has decreased by -28.91%, while in the last 12 months, it has decreased by -23.46%.

Market capitalization represents the total value of NervGen Pharma Corp as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

NGEN Market Cap Formula = Stock Price * Shares Outstanding

The market cap of NGEN helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NGEN Market Cap History

DateMarket CapChange
Dec 1, 2025$324.35M+80.10%
Nov 3, 2025$180.10M-2.69%
Oct 1, 2025$185.08M-2.76%
Sep 2, 2025$190.34M+6.16%
Aug 1, 2025$179.30M-1.13%
Jul 1, 2025$181.35M-2.98%
Jun 2, 2025$186.93M+16.63%
May 1, 2025$160.27M+8.14%
Apr 1, 2025$148.21M+9.15%
Mar 3, 2025$135.78M-4.30%
Feb 3, 2025$141.88M-13.02%
Jan 2, 2025$163.12M+12.62%

NGEN End of Year Market Cap History

DateMarket CapChange
2026$335.89M-23.46%
2025$438.85M+186.32%
2024$153.28M+26.26%
2023$121.40M+73.85%
2022$69.83M+19.55%
2021$58.42M

FAQs About NervGen Pharma Corp (NGEN) Market Cap

As of Feb 3, 2026, the market capitalization of NGEN is $335.89M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, NervGen Pharma Corp’s market capitalization has decreased by -28.23%, changing from $468.02M to $335.89M as of Feb 3, 2026.

In the last 3 months, NervGen Pharma Corp’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, NervGen Pharma Corp’s market capitalization increased from $153.28M in January to $438.85M in December, reflecting a 186.32% change.

In the past five years, NGEN has had a compound annual growth rate (CAGR) of 49.68% in market capitalization. This means its market cap has grown at an average rate of 49.68% per year.

NervGen Pharma Corp (NGEN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.